Prostate cancer patients with metastatic disease and low-volume primary tumors appear to have a poor prognosis, according to ...
New research presented at the 2025 International Kidney Cancer Symposium found that patients with localized renal cell ...
Genitourinary cancers require individualized treatment plans based on type, stage, and patient health, utilizing imaging, biopsy, and various therapies. Combining therapies with complementary ...
Sarcopenia as a marker to assess the surveillance necessity after a 5-year cancer-free period in patients who undergo radical cystectomy: A multi-institutional retrospective study.
CRANBURY, N.J.--(BUSINESS WIRE)--#Cancer--OncLive®, the nation’s leading multimedia resource focused on providing oncology professionals with the most current and insightful information they need to ...
Recent years have seen remarkable progress in the application of radiotherapy for the management of genitourinary (GU) malignancies, including prostate, ...
This Collection provides a comprehensive overview of the crucial role of biomarkers in personalizing genitourinary cancer care. We have brought together informative Review and Perspective articles ...
Vir Biotechnology, Inc. (Nasdaq: VIR) today provided key program updates, including new positive data from the ongoing SOLSTICE Phase 2 trial in chronic hepatitis delta (CHD). Participants receiving ...
Real-world genomic analysis highlights unmet medical need in GU cancer patients with TSC1/2 inactivating alterations LOS ANGELES, Jan. 26, 2024 /PRNewswire/ -- Aadi Bioscience (AADI), Inc. , a ...
This study validated PROSTOX as predicting radiotherapy-induced genitourinary toxicity, which can be differentiated into acute and chronic with mirSNP-based signatures, in patients with prostate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback